INVIVO AND INVITRO PHARMACOLOGY OF SR48,968 AS TACHYKININ NK-2 RECEPTOR ANTAGONIST

被引:0
|
作者
GIULIANI, S [1 ]
PATACCHINI, R [1 ]
GIACHETTI, A [1 ]
MAGGI, CA [1 ]
机构
[1] A MENARINI PHARMACEUT,DEPT PHARMACOL,I-50131 FLORENCE,ITALY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S63 / S63
页数:1
相关论文
共 50 条
  • [11] A POTENT AND SELECTIVE AGONIST FOR NK-2 TACHYKININ RECEPTOR
    ROVERO, P
    PESTELLINI, V
    PATACCHINI, R
    GIULIANI, S
    SANTICIOLI, P
    MAGGI, CA
    MELI, A
    GIACHETTI, A
    PEPTIDES, 1989, 10 (03) : 593 - 595
  • [12] Successful bridging from a peptide to a non peptide antagonist at the human tachykinin NK-2 receptor
    Altamura, M
    Canfarini, F
    Catalioto, RM
    Guidi, A
    Pasqui, F
    Renzetti, AR
    Triolo, A
    Maggi, CA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (20) : 2945 - 2948
  • [13] Chemoenzymatic synthesis of a non-peptide tachykinin NK-2 antagonist
    Carnell, AJ
    Hernandez, MLE
    Pettman, A
    Bickley, JF
    TETRAHEDRON LETTERS, 2000, 41 (35) : 6929 - 6933
  • [14] INVIVO PHARMACOLOGY OF [BETA-ALA8]NEUROKININ A-(4-10), A SELECTIVE NK-2 TACHYKININ RECEPTOR AGONIST
    MAGGI, CA
    GIULIANI, S
    BALLATI, L
    ROVERO, P
    ABELLI, L
    MANZINI, S
    GIACHETTI, A
    MELI, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 177 (1-2) : 81 - 86
  • [15] ANTITUSSIVE EFFECT OF SR 48968, A NONPEPTIDE TACHYKININ NK(2) RECEPTOR ANTAGONIST
    ADVENIER, C
    GIRARD, V
    NALINE, E
    VILAIN, P
    EMONDSALT, X
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (01) : 169 - 171
  • [16] NK-2 is the predominant tachykinin receptor subtype in the swine ureter
    Jerde, TJ
    Saban, R
    Bjorling, DE
    Nakada, SY
    BJU INTERNATIONAL, 1999, 83 (03) : 312 - 317
  • [17] In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist
    Kudlacz, EM
    Shatzer, SA
    Knippenberg, RW
    Logan, DE
    Poirot, M
    VanGiersbergen, PLM
    Burkholder, TP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (02): : 840 - 851
  • [18] DESIGN AND SYNTHESIS OF A PROTOTYPE MODEL ANTAGONIST OF TACHYKININ NK-2 RECEPTOR (VOL 4, PG 1397, 1994)
    HANESSIAN, S
    RONAN, B
    LAOUI, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (12) : 1321 - 1321
  • [19] Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor
    Meini, S
    Catalani, C
    Bellucci, F
    Cucchi, P
    Giuliani, S
    Zappitelli, S
    Rotondaro, L
    Pasqui, F
    Guidi, A
    Altamura, M
    Giolitti, A
    Maggi, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 516 (02) : 104 - 111
  • [20] The tachykinin NK-2 receptor antagonist nepadutant is a powerful inhibitor of small rowel motility stimulated by neurokinin a in man.
    Loerdal, M
    Navalesi, G
    Maggi, C
    Theodorsson, E
    Hellstroem, PM
    GASTROENTEROLOGY, 1999, 116 (04) : A1032 - A1032